These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23129378)

  • 1. Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?
    Jansen EP; Boot H; van de Velde CJ; van Sandick J; Cats A; Verheij M
    Recent Results Cancer Res; 2012; 196():229-40. PubMed ID: 23129378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
    Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
    J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resected gastric cancer with D2 dissection: advances in adjuvant chemoradiotherapy and radiotherapy techniques.
    Wu Q; Li G; Xu F
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):703-13. PubMed ID: 26004039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting the best treatment for an individual patient.
    Bittoni A; Faloppi L; Giampieri R; Cascinu S
    Recent Results Cancer Res; 2012; 196():307-18. PubMed ID: 23129382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
    McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
    Cochrane Database Syst Rev; 2003; (4):CD001964. PubMed ID: 14583942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The essentials of locoregional control in the treatment of gastric cancer.
    den Dulk M; Verheij M; Cats A; Jansen EP; Hartgrink HH; Van de Velde CJ
    Scand J Surg; 2006; 95(4):236-42. PubMed ID: 17249271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future perspectives in gastric cancer management.
    Roukos DH
    Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer.
    McCulloch P; Niita ME; Kazi H; Gama-Rodrigues JJ
    Br J Surg; 2005 Jan; 92(1):5-13. PubMed ID: 15635680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of patients with lymph node metastasis from gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection--do N3 patients benefit from additional radiation?
    Fan M; Li G; Shen L; Zhang H; Liang L; Zhang Z
    Br J Radiol; 2016; 89(1059):20150758. PubMed ID: 26728420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
    J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
    Montenegro P; Flores L; Quintana S; Casanova L; Ruíz E; León J; Mantilla R
    Rev Gastroenterol Peru; 2013; 33(1):34-8. PubMed ID: 23539054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma].
    Shah MA; Kelsen DP
    Chirurg; 2002 Apr; 73(4):325-30. PubMed ID: 12063916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended lymphadenectomy in gastric cancer: when, for whom and why.
    Roukos DH
    Ann R Coll Surg Engl; 1998 Jan; 80(1):16-24. PubMed ID: 9579122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node dissection in resectable advanced gastric cancer.
    de Steur WO; Dikken JL; Hartgrink HH
    Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.